P2RX7 and cancer: In contrast, P2X7 immunoreactivity in cancer tissues was significantly lesser than in normal epidermal or papilloma tissues (Figs. 7E, F), and data analysis of the P2X7 immunostaining revealed a four fold lesser P2X7 immunoreactivity in cancer than in normal tissues (Fig. 7G).